Cardiome Pharma (CRME) Reports a Q1 Loss
Cardiome Pharma Corp. (NASDAQ: CRME) reports a Q1 loss of $0.01 vs. consensus of $0.17 profit. Revenues were $21.1 million vs. $26.78 million consensus.
Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).
[SM]
Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).
[SM]
You May Also Be Interested In
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
- UPDATE: Stein Mart (SMRT) Reports Q1 Adj-EPS of 32c, Beats by 2c
- Autodesk, Inc. (ADSK) Reports In-Line Q1 EPS; Guides In-line
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
